Labcorp Holdings Inc. Files 8-K on Financials
Ticker: LH · Form: 8-K · Filed: Oct 24, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Oct 24, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Labcorp dropped its 8-K today, check the financials.
AI Summary
Labcorp Holdings Inc. filed an 8-K on October 24, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits. The company's principal executive offices are located at 358 South Main Street, Burlington, North Carolina.
Why It Matters
This 8-K filing provides an update on Labcorp's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any unusual risks or events.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- October 24, 2024 (date) — Filing Date
- 358 South Main Street, Burlington, North Carolina 27215 (location) — Principal Executive Offices
- 336 - 229-1127 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Labcorp Holdings Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K filed?
This 8-K was filed on October 24, 2024.
What is the official name of the company filing this report?
The official name of the company filing this report is LABCORP HOLDINGS INC.
Where are Labcorp's principal executive offices located?
Labcorp's principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
What is the telephone number listed for Labcorp Holdings Inc.?
The telephone number listed for Labcorp Holdings Inc. is 336 - 229-1127.
Filing Stats: 377 words · 2 min read · ~1 pages · Grade level 11.6 · Accepted 2024-10-24 06:58:10
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20241024.htm (8-K) — 23KB
- form8-kerex991for3q24.htm (EX-99.1) — 481KB
- labcorp_logoxhorizontalxcoa.jpg (GRAPHIC) — 108KB
- 0000920148-24-000115.txt ( ) — 800KB
- lh-20241024.xsd (EX-101.SCH) — 2KB
- lh-20241024_lab.xml (EX-101.LAB) — 22KB
- lh-20241024_pre.xml (EX-101.PRE) — 13KB
- lh-20241024_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated October 24, 2024 issued by Labcorp titled "Labcorp Announces 2024 Third Quarter Results"
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary October 24, 2024